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Abstract   
Introduction: In recent years the relationship between electromagnetic fields and coronary 
artery disease is attracted a considerable attention. Low density lipoprotein (LDL) oxidation is 
the initial step in the development of atherosclerosis. Paraoxonase1 (PON1) protects LDL and 
High density lipoprotein (HDL) against oxidative processes, thus preventing the formation of 
atherogenic (oxidized-LDL) ox-LDL molecules. In this study we investigated the effects of 
static magnetic fields (SMFs) and extremely low frequency electromagnetic fields (ELF-
EMFs) on PON1 activity as one of the independent risk factors for cardiovascular disease. 
Materials and methods: Pooled serum sample of 20 healthy men were exposed to SMFs and 
EMFs flux densities of 0.125, 0.25, 0.5, 1, 2, 3 and 4 mT for 60, 120 and 180 minutes at 25°C 
and then PON1 activity was measured spectrophotometrically using paraoxon as substrate. 
Results: EMFs of 0.125-1 mT had no effect on PON1 activity. Exposure to magnetic flux 
density of 2 mT leads to a significant increase in PON1 activity in 1 hour (P <0.05). Magnetic 
flux density of 3 and 4 mT, after 1hour of exposure, lead to an increase of PON1 activity to 
1.2% and 2.8%, respectively (P <0.01).  
Conclusion: PON1 activity is influenced by a variety of agents like environmental, 
pharmacological, and lifestyle factors as well as age and sex. According to the finding of this 
study ELF-EMFs can alternate the serum activity of PON1 in vitro. If this effect of EMFs on 
PON1 activity has proven in vivo, it can be considered as an effective factor in coronary artery 
disease.  
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Introduction  
In today’s world, with the progression of 
technology and continuous exposure of 
human to a diverse range of 
electromagnetic fields (EMFs), 
investigation on the biological effects and 
health implications of EMFs matters a lot. 
Meanwhile evaluation of the effects of 
EMFs on cardiovascular disease (CVD) has 
attracted considerable attention (1). 
Coronary artery disease (CAD) is the most 
common type of CVD, the greatest current 
public health problem, in the 21st century 
(2). CAD is a state of degenerative and 
dynamic alteration in the arterial walls of 
heart which results from the accumulation 
of lipids, especially cholesterol and 
formation of atherosclerosis plaques (3). 
Among the lipoproteins, high density 
lipoprotein (HDL) and low density 
lipoprotein (LDL) play a significant role in 
atherosclerosis process (4). LDL 
modification, especially formation of 
oxidized LDL (ox-LDL), is an early step in 
promotion of atherosclerosis which leads to 
the macrophages accumulation in the 
arterial wall and transformation in to the 
foam cells (5). On the other hand, HDL has 
antioxidant activities (6) and inhibit the 
oxidation of LDL (7). This antioxidant 
property of HDL, in part, resulted from the 
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capacity of paraoxonase-1 (PON1), an 
enzyme associated with HDL structures, to 
hydrolyze the oxidized phospholipids and 
hydroxides of cholesteryl linoleate 
contained in ox-LDL molecules (8). PON1 
also limits the process of foam cell 
formation and reduces the formation of 
atherosclerotic plaques through 
suppressing the differentiation of 
monocytes into macrophages (9).  
Decreased PON1 activity has been seen in 
several diseases such as CAD (10). It is 
evident that PON1 activity is influenced by 
a variety of agents like pharmacological, 
environmental, and lifestyle factors (11-
13). It is evident that EMFs can influence 
the activity of enzymes involved various 
metabolic pathways in plants (14-16), 
cultured cells (17), and animals (18).  
Investigation on rats shown that exposure to 
extremely low frequency magnetic fields 
(ELF-MF) could impair oxidant-
antioxidant function and might increase 
oxidative stress and lipid peroxidation in a 
time dependent manner (18). The aim of 
this study is to investigate the effects of 
static magnetic fields (SMFs) and ELF-
MFs on human serum PON1 activity in 
vitro in a common intensities we expose to 
daily. 
Materials and methods 
Serum preparation and enzyme activity 
assay: A pooled serum was prepared from 
12 h fasting blood samples of 20 donors. 
Blood samples (2 ml) were collected by 
venepuncturing after 12-14 h fasting. 
Serum was separated by centrifugation at 
3000 rpm for 15 min. A 100 μl aliquot of 
serum was stored at -80°C until the 
measurement of serum PON1 activity. 
PON1 activity was determined using 2 mM 
paraoxon (diethyl p-nitro-phenyl 
phosphate, Sigma chemical Co., USA) as 
the substrate in 100 mM tris buffer, pH 8.0, 
containing 2 mM of CaCl2. A 40 μl aliquot 
of pooled serum was added to 500 μl of the 
substrate medium. The generation of p-
nitrophenol (initial rate of hydrolysis) was 
determined at 412 nm using UV-VIS-3100 
spectrophotometer (Shimadzu, Kyoto, 
Japan) over a period of 2 min (19). The 
molar extinction coefficient of p-
nitrophenol was considered 17,000 M/cm 
(20). All assays were performed in 
duplicate at 25°C. The between assay and 
within assay coefficient of variation (CV) 
for the method was 3.6% and 5.1%, 
respectively. 
SMF and EMF Exposure System: A 
solenoid cylinder with a diameter of 12 cm, 
height of 30 cm, and 1200 turns was used to 
generate SMF and EMF. For producing 
suitable static magnetic flux densities, a 
regulated direct current (DC) power supply 
(Model 7321, Sanjesh, Tehran, Iran) and for 
producing suitable electromagnetic flux 
densities, a voltage regulator AC power 
supply (model: TDGC2, 220v, 50-60 Hz, 
Delta International Electric Co, Shanghai, 
China) have been applied. The solenoid was 
located inside a 25 ºC ventilated incubator 
(Parsazma, Tehran, Iran), so the 
temperature inside the solenoid was 
controlled exactly during the exposure. 
Before enzyme activity measurement, 
serum samples (inside a quartz cuvette) 
were put in the centre of the solenoid for 
certain times. The produced SMF and EMF 
at the exact site of cuvette location was 
measured using a digital teslameter with a 
3-D sensor (Holaday, Eden Prairie, MN) 
(21, 22). 
Statistics analysis  
Statistical analysis was performed using 
SPSS 16.0 (SPSS Inc., Chicago, IL). The 
results are presented as mean values ± 
standard deviation. A probability of 0.05 
was considered statistically significant. 
Non-parametrical Mann–Whitney–
Wilcoxon test was used to compare the data 
between control and exposed samples. 
Comparison of data between different 
magnetic flux densities and different 
exposure times was examined with the non-
parametric Kruskal–Wallis H-test for 







































The impact of SMFs of 0.125, 0.5, 1, 2, 3 
and 4 mT on serum PON1 activity is shown 
in Table1. Static magnetic flux density of 
0.125 mT had no effect on PON1 activity. 
Static magnetic flux densities of 0.25 and 
0.5 mT lead to an increase (8.1% and 1.7%, 
respectively) in PON1 activity at the first 
hour of exposure. Exposure of serum to 1 
mT SMF for 3 hours decreased the PON1 
activity to 1.7% (P <0.05). As indicated in 
Table 1, PON1 activity significantly 
increased only at the first hour of exposure 
to 2mT SMF (P <0.05). SMFs of 3 and 4 
mT lead to the increase in PON1 activity in 
all applied times of exposure.
 
Table1.  Effect of SMFs on serum PON1 activity after 3 hours of exposure. 
 Time of exposure (min) 
SMF (mT) 0 60 120 180 
0.125 77.93 ± 0. 68 77.82 ± 0.5 78.56 ± 0.23 78.26 ± 0.4 
0.25 77.40 ± 0.4 83.66 ± 0.87** 82.01 ± 0.35** 83.83 ± 0.51** 
0.5 77.85 ± 0.4 79.21 ± 0.58* 80.32 ± 0.61** 79.82 ± 0.61** 
1 78.09 ± 0.41 78.42 ± 0.42 77.94 ± 0.18 76.77 ± 0.68* 
2 78.27 ± 0.42 79.26 ± 0.33* 78.07 ± 0.45 77.48 ± 0.28 
3 78.15 ± 0.38 82.55 ± 0.33** 82.49 ± 0.30** 80.25 ± 0.24** 
4 78.45 ± 1.34 87.41 ± 0.35** 83.35 ± 0.38** 82.51 ± 0.40** 
Serum PON1 activity was determined using paraoxon as substrate at 25 ˚C within two minutes. The data shows 
the level of PON1 activity in U/l and the values expressed as mean ± standard derived from the five separate tests. 
*P <0.05, **P <0.01  
 
The impact of extremely low frequency 
EMFs of 0.125, 0.5, 1, 2, 3 and 4 mT on 
serum PON1 activity is indicated in Table 
2. Electromagnetic flux densities of 0.125 
to 1 mT had no effect on PON1 activity 
even after 3 hours of exposure. Magnetic 
flux density of 2 mT increases the activity 
of PON1 just at the first hour of exposure 
(P <0.05). The magnetic fields of 3 and 4 
mT result in a significant increase in 
enzyme activity, reaching a maximum of 
1.2% and 8.2%.
 
Table2.  Effect of EMFs on serum PON1 activity after 3 hours of exposure. 
 Time of exposure (min) 
EMF (mT) 0  60   120 180 
0.125 84.63 ± 0. 63 85.0 ± 0.36 84.96 ± 0.35 84.83 ± 0.4 
0.25 84.96 ± 0.57 84.64 ± 0.61 84.98 ± 0.51 84.56 ± 0.44 
0.5 85.26 ± 0.53 85.12 ± 0.29 84.76 ± 0.45 84.69± 0.35 
1 85.15 ± 0.49 85.76 ± 0.51 85.73 ± 0.40 85.80± 0.34 
2 84.75 ± 0.40 85.93 ± 0.45* 85.81 ± 0.50 85.89 ± 0.29 
3 85.31 ± 0.49 87.09 ± 0.39** 87.01 ± 0.48** 86.88 ± 0.43** 
4 85.11 ± 0.49 87.16 ± 0.5** 87.48 ± 0.45** 87.51± 0.31** 
Serum PON1 activity was determined using paraoxon as substrate at 25 ˚C within two minutes. The data shows 
the level of PON1 activity in U/l and the values expressed as mean ± standard derived from the five separate tests. 
*P <0.05, **P <0.01 
 
Discussion  
This study was undertaken to investigate 
the effects of SMFs and extremely low 
frequency EMFs on human serum PON1 
activity in vitro. According to the result of 
our study, SMFs and ELF-EMFs can 
impact the activity of PON1, although 
changing the activity of PON1 under the 
SMF doesn’t follow a specific pattern and 
is not dependent on the time of exposure. 
Exposure to magnetic flux density of 2 mT 
leads to a significant increase in PON1 
activity in 2 hours. Magnetic flux density of 
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activity to 1.2% and 2.8% after 1 h of 
exposure respectively.  
The earth’s magnetic field is about 0.03 to 
0.07 mT, which is a natural component of 
the environment for living organisms. 
Magnetic fields much weaker than the 
earth’s field can affect living organisms 
through the chemical processes and effect 
on the radical pair recombination (23). A 
review by Belyavskaya suggested that 
prolonged exposure of plants to a weak 
magnetic field might cause different 
biological effects at the cellular, tissue and 
organ levels (24). 
Induction of electrical charges and currents 
is a primary action of MF in biological 
systems (25). Influence on nuclear spins of 
paramagnetic molecules is one of the major 
molecular effects of MFs which plays an 
important role in chemical reaction when 
two molecules with unpaired electrons are 
formed following the disruption of 
chemical bound (26).  
Study on the impact of electromagnetic 
fields on the enzymes activity is a new 
concept in science and there are only a few 
publications on this subject in accessible 
literature. Enzymes contain protein 
structures that organize the dipoles and 
charges into an especial pattern that can 
orient specifically the electric field they 
exert onto particular regions of their bound 
substrates (27-30). This effect is called 
electrostatic preorganization. A 
reorganized enzyme active site can create 
an electric field with a particular orientation 
which is controlled by the protein’s folded 
structure and optimizes a particular 
electrostatic interaction (28).  
The impact of a frequent magnetic field on 
the activity of peroxidase, catalase and 
superoxide dismutase (respiratory 
enzymes) was investigated before (31, 32). 
According to the report of Seifirad et al, 
acute ELF-MF exposure increased lipid 
peroxidation and antioxidant serum activity 
(PON1 activity) in rat. These changes are 
irreversible in chronic exposure. They 
believe that the effects of ELF-MF evoke 
antioxidant system to recompense toxic 
effects of produced reactive oxygen species 
(18).  
Shaoyi et al, investigate the effects of 
magnetic field on the activity of α-amylase 
purified from Bacillus subtilis. They report 
that magnetic field had a considerable 
effect on activity, Km, Vm and secondary 
conformation of α-amylase in a dose and 
time dependent manner. The values of Km 
and Vm reduced with increase in the 
intensity of magnetic field (33). 
Conclusion 
ELF- MF exposure could impair oxidant 
antioxidant balance and might increase 
oxidative stress and lipid peroxidation. 
Antioxidant defect could be repaired after 
exposure; however it might depends on the 
duration and continuity of ELF-MF 
exposure. This investigation indicates that 
PON1 activity can affected by static and 
electromagnetic fields in vitro, whereas 
increases of magnetic field intensity and 
exposure time do not cause linear increases 
for PON1 activity. The possible reason for 
change in PON1 activity and kinetic 
parameters may be the secondary 
conformation changed in enzyme structure 
following the exposure to static and 
electromagnetic fields.  
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